TopicFinancing and Dilution in Start-Up CompaniesDescriptionJoin us on June 2nd to learn business strategies around equity negations, fundraising, and dilution for life science start-ups.
Speaker, James Stubbs, PhD has over 20 years of commercialization experience and has held senior executive roles in five medical device startups including founder, CEO, CTO, CSO and VP Scientific Affairs. Since 2005 he has contributed to four successful startup exits valued at over $500M. James is currently teaching medical device design and Capstone in the Biomedical Engineering Department at Georgia Tech and is an active private investor.
This is the tenth session in the Bench2Market Talks series which was created to provide commercialization guidance to the university research community. Series topics include how to take your technology from the lab to commercial success and explore market opportunities surrounding entrepreneurial and innovative ideas.
Who Should Attend?
Events are open to entrepreneurs in the life sciences, Georgia CTSA, Georgia Tech and Emory University faculty, staff, graduate students, post-doc, residents and fellows.
Where can I find information about the entire Bench2Market Talks Series?
For details and registration links for all events in the series, visit https://biolocity.gatech.edu/bench2market/Time
Jun 2, 2021 11:30 AM in Eastern Time (US and Canada)